These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34901554)

  • 1. Two-stage degradation and novel functional endothelium characteristics of a 3-D printed bioresorbable scaffold.
    Yin T; Du R; Wang Y; Huang J; Ge S; Huang Y; Tan Y; Liu Q; Chen Z; Feng H; Du J; Wang Y; Wang G
    Bioact Mater; 2022 Apr; 10():378-396. PubMed ID: 34901554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between arterial components and bioresorbable, 3-D printed poly-L-lactic acid scaffolds.
    Wang Y; Huang Y; Du R; Ge S; Li Y; Wang G; Wang Y; Yin T
    Biomater Sci; 2022 Sep; 10(18):5121-5133. PubMed ID: 35920380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical properties and degradation of drug eluted bioresorbable vascular scaffolds prepared by three-dimensional printing technology.
    Zhang Y; Zhao J; Yang G; Zhou Y; Gao W; Wu G; Li X; Mao C; Sheng T; Zhou M
    J Biomater Sci Polym Ed; 2019 May; 30(7):547-560. PubMed ID: 30897033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioresorbable Scaffold-Based Controlled Drug Delivery for Restenosis.
    Tesfamariam B
    J Cardiovasc Transl Res; 2019 Jun; 12(3):193-203. PubMed ID: 30367355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Characterization of Biomechanical Behavior and Healing Profile of a Novel Ultra-High-Molecular-Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.
    Cheng Y; Gasior P; Shibuya M; Ramzipoor K; Lee C; Estrada EA; Dokko D; McGregor JC; Conditt GB; Kaluza GL; Granada JF
    Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27694138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.
    Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S
    JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro mechanical behavior and in vivo healing response of a novel thin-strut ultrahigh molecular weight poly-l-lactic acid sirolimus-eluting bioresorbable coronary scaffold in normal swine.
    Cheng Y; Gasior P; Ramzipoor K; Lee C; McGregor JC; Conditt GB; McAndrew T; Kaluza GL; Granada JF
    Int J Cardiol; 2019 Jul; 286():21-28. PubMed ID: 30967275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late positive remodeling and late lumen gain contribute to vascular restoration by a non-drug eluting bioresorbable scaffold: a four-year intravascular ultrasound study in normal porcine coronary arteries.
    Strandberg E; Zeltinger J; Schulz DG; Kaluza GL
    Circ Cardiovasc Interv; 2012 Feb; 5(1):39-46. PubMed ID: 22253358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical comparative assessment of a dedicated pediatric poly-L-lactic-acid-based bioresorbable scaffold with a low-profile bare metal stent.
    Shibbani K; De Lima E Silva Bagno L; Poulin MF; Matella T; Diab K; Kavinsky C; Ramesh N; Bhat V; Hijazi ZM; Kenny D
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):878-888. PubMed ID: 32294303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-head comparison of a drug-free early programmed dismantling polylactic acid bioresorbable scaffold and a metallic stent in the porcine coronary artery: six-month angiography and optical coherence tomographic follow-up study.
    Durand E; Sharkawi T; Leclerc G; Raveleau M; van der Leest M; Vert M; Lafont A
    Circ Cardiovasc Interv; 2014 Feb; 7(1):70-9. PubMed ID: 24368820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inconsistency in Graft Outcome of Bilayered Bioresorbable Supramolecular Arterial Scaffolds in Rats.
    Duijvelshoff R; di Luca A; van Haaften EE; Dekker S; Söntjens SHM; Janssen HM; Smits AIPM; Dankers PYW; Bouten CVC
    Tissue Eng Part A; 2021 Jul; 27(13-14):894-904. PubMed ID: 32873211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
    Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Biomechanical Behavior and Healing Profile of a Novel Thinned Wall Ultrahigh Molecular Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.
    Cheng Y; Gasior P; Xia JG; Ramzipoor K; Lee C; Estrada EA; Dokko D; McGregor JC; Conditt GB; McAndrew T; Kaluza GL; Granada JF
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti-proliferative drugs: Two-year imaging results in humans.
    Moncada M; Delgado JA; Colombo A; Gasior P; Ramzipoor K; Estrada A; Lee C; Dokko D; Granada JF
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E246-E253. PubMed ID: 29243353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
    Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research Progress of Bioresorbable Scaffold].
    Liu Q; Cui S; Zhao Q; Chen M; Zheng B; Huo Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Sep; 41(5):357-361. PubMed ID: 29862725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of Degradation Behavior of Bioresorbable Cardiovascular Scaffolds.
    Luo Q; Huang C; Wang S; Meng J; Li Z; Chang Z; Zhu Y; Hua Z
    Cardiovasc Eng Technol; 2015 Mar; 6(1):71-9. PubMed ID: 26577104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspectives on bioresorbable scaffolds in coronary intervention and other fields.
    Wu X; Wu S; Kawashima H; Hara H; Ono M; Gao C; Wang R; Lunardi M; Sharif F; Wijns W; Serruys PW; Onuma Y
    Expert Rev Med Devices; 2021 Apr; 18(4):351-365. PubMed ID: 33739213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.